Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

An appraisal of oral retinoids in the treatment of pachyonychia congenita.

Gruber R, Edlinger M, Kaspar RL, Hansen CD, Leachman S, Milstone LM, Smith FJ, Sidoroff A, Fritsch PO, Schmuth M.

J Am Acad Dermatol. 2012 Jun;66(6):e193-9. doi: 10.1016/j.jaad.2011.02.003. Epub 2011 May 24.

PMID:
21601946
2.

Filaggrin genotype in ichthyosis vulgaris predicts abnormalities in epidermal structure and function.

Gruber R, Elias PM, Crumrine D, Lin TK, Brandner JM, Hachem JP, Presland RB, Fleckman P, Janecke AR, Sandilands A, McLean WH, Fritsch PO, Mildner M, Tschachler E, Schmuth M.

Am J Pathol. 2011 May;178(5):2252-63. doi: 10.1016/j.ajpath.2011.01.053.

3.
4.

Increased pachyonychia congenita severity in patients with concurrent keratin and filaggrin mutations.

Gruber R, Wilson NJ, Smith FJ, Grabher D, Steinwender L, Fritsch PO, Schmuth M.

Br J Dermatol. 2009 Dec;161(6):1391-5. doi: 10.1111/j.1365-2133.2009.09471.x. Epub 2009 Sep 28.

PMID:
19785597
5.

Comparison of metallothionein-overexpression with sentinel lymph node biopsy as prognostic factors in melanoma.

Weinlich G, Topar G, Eisendle K, Fritsch PO, Zelger B.

J Eur Acad Dermatol Venereol. 2007 May;21(5):669-77.

PMID:
17447982
6.

Filaggrin mutations p.R501X and c.2282del4 in ichthyosis vulgaris.

Gruber R, Janecke AR, Fauth C, Utermann G, Fritsch PO, Schmuth M.

Eur J Hum Genet. 2007 Feb;15(2):179-84. Epub 2006 Dec 13.

7.

Prognosis of lymphomatoid papulosis.

Gruber R, Sepp NT, Fritsch PO, Schmuth M.

Oncologist. 2006 Sep;11(8):955-7; author reply 957. No abstract available.

8.

Metallothionein - overexpression as a highly significant prognostic factor in melanoma: a prospective study on 1270 patients.

Weinlich G, Eisendle K, Hassler E, Baltaci M, Fritsch PO, Zelger B.

Br J Cancer. 2006 Mar 27;94(6):835-41.

9.

Metallothionein-overexpression as a prognostic factor for progression and survival in melanoma. A prospective study on 520 patients.

Weinlich G, Bitterlich W, Mayr V, Fritsch PO, Zelger B.

Br J Dermatol. 2003 Sep;149(3):535-41.

PMID:
14510986
10.

Topical corticosteroid therapy for acute radiation dermatitis: a prospective, randomized, double-blind study.

Schmuth M, Wimmer MA, Hofer S, Sztankay A, Weinlich G, Linder DM, Elias PM, Fritsch PO, Fritsch E.

Br J Dermatol. 2002 Jun;146(6):983-91.

PMID:
12072066
11.

Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells.

Schuler-Thurner B, Schultz ES, Berger TG, Weinlich G, Ebner S, Woerl P, Bender A, Feuerstein B, Fritsch PO, Romani N, Schuler G.

J Exp Med. 2002 May 20;195(10):1279-88. Erratum in: J Exp Med. 2003 Feb 3;197(3):395..

12.

Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.

Fritsch PO, Sidoroff A.

Am J Clin Dermatol. 2000 Nov-Dec;1(6):349-60. Review.

PMID:
11702611
13.

Permeability barrier function of skin exposed to ionizing radiation.

Schmuth M, Sztankay A, Weinlich G, Linder DM, Wimmer MA, Fritsch PO, Fritsch E.

Arch Dermatol. 2001 Aug;137(8):1019-23.

PMID:
11493094
14.

Therapeutic use of interferon-alpha for lymphomatoid papulosis.

Schmuth M, Topar G, Illersperger B, Kowald E, Fritsch PO, Sepp NT.

Cancer. 2000 Oct 1;89(7):1603-10.

PMID:
11013377
15.

Interferon-gamma in the treatment of systemic sclerosis: a randomized controlled multicentre trial.

Grassegger A, Schuler G, Hessenberger G, Walder-Hantich B, Jabkowski J, MacHeiner W, Salmhofer W, Zahel B, Pinter G, Herold M, Klein G, Fritsch PO.

Br J Dermatol. 1998 Oct;139(4):639-48.

PMID:
9892907
16.

Spontaneous or interferon-gamma-induced T-cell infiltration, HLA-DR and ICAM-1 expression in genitoanal warts are associated with TH1 or mixed TH1/TH2 cytokine mRNA expression profiles.

Grassegger A, Rollinger-Holzinger I, Zelger BW, Heim K, Zwierzina H, Fritsch PO, Höpfl RM.

Arch Dermatol Res. 1997 Apr;289(5):243-50.

PMID:
9164632
17.

Dermal spindle cell lipoma: plexiform and nodular variants.

Zelger BW, Zelger BG, Plörer A, Steiner H, Fritsch PO.

Histopathology. 1995 Dec;27(6):533-40.

PMID:
8838333
18.

[Differential livedo syndrome diagnosis].

Zelger B, Plörer A, Sepp N, Fritsch PO.

Hautarzt. 1995 May;46(5):369-79; quiz 377-8. Review. German. No abstract available.

PMID:
7607907
19.

Mutations of keratin 9 in two families with palmoplantar epidermolytic hyperkeratosis.

Bonifas JM, Matsumura K, Chen MA, Berth-Jones J, Hutchison PE, Zloczower M, Fritsch PO, Epstein EH Jr.

J Invest Dermatol. 1994 Oct;103(4):474-7.

20.

Deep penetrating dermatofibroma versus dermatofibrosarcoma protuberans. A clinicopathologic comparison.

Zelger B, Sidoroff A, Stanzl U, Fritsch PO, Ofner D, Zelger B, Jasani B, Schmid KW.

Am J Surg Pathol. 1994 Jul;18(7):677-86.

PMID:
8017562
21.

Proliferating dendritic cell progenitors in human blood.

Romani N, Gruner S, Brang D, Kämpgen E, Lenz A, Trockenbacher B, Konwalinka G, Fritsch PO, Steinman RM, Schuler G.

J Exp Med. 1994 Jul 1;180(1):83-93.

22.

Immunohistochemically demonstrated metallothionein expression in malignant melanoma.

Zelger B, Hittmair A, Schir M, Ofner C, Ofner D, Fritsch PO, Böcker W, Jasani B, Schmid KW.

Histopathology. 1993 Sep;23(3):257-63.

PMID:
8225244
23.

Sneddon's syndrome: diagnosis by skin biopsy and MRI in 17 patients.

Stockhammer G, Felber SR, Zelger B, Sepp N, Birbamer GG, Fritsch PO, Aichner FT.

Stroke. 1993 May;24(5):685-90.

PMID:
8488523
24.

Enzyme-linked immunosorbent assay for detection of antibodies to the unmodified beta-lactam ring.

Klein GF, Stanzl U, Fritsch PO, Varga JM.

Allergy. 1993 Apr;48(3):151-7.

PMID:
8506980
25.

Sneddon's syndrome. A long-term follow-up of 21 patients.

Zelger B, Sepp N, Stockhammer G, Dosch E, Hilty E, Ofner D, Aichner F, Fritsch PO.

Arch Dermatol. 1993 Apr;129(4):437-47. Review.

PMID:
8466214
26.

Can cyclosporin A induce permanent remission of atopic dermatitis?

Sepp N, Fritsch PO.

Br J Dermatol. 1993 Feb;128(2):213-6.

PMID:
8457456
27.

Retinoids in psoriasis and disorders of keratinization.

Fritsch PO.

J Am Acad Dermatol. 1992 Dec;27(6 Pt 2):S8-14. Review.

PMID:
1460124
28.

Adjuvant treatment of recalcitrant genitoanal warts with systemic recombinant interferon-alpha-2c.

Höpel RM, Sandbichler M, Zelger BW, Conrad FG, Fritsch PO.

Acta Derm Venereol. 1992 Sep;72(5):383-6.

PMID:
1361292
29.

Life history of cutaneous vascular lesions in Sneddon's syndrome.

Zelger B, Sepp N, Schmid KW, Hintner H, Klein G, Fritsch PO.

Hum Pathol. 1992 Jun;23(6):668-75.

PMID:
1592390
30.

Keratoacanthomas: human papillomavirus associated?

Höpfl RM, Schir MM, Fritsch PO.

Arch Dermatol. 1992 Apr;128(4):563-4. No abstract available.

PMID:
1316106
31.

[Necrotizing vasculitis. II. Clinical syndromes].

Fritsch PO.

Hautarzt. 1991 Oct;42(10):661-70. German. No abstract available.

PMID:
1684577
32.

[Necrotizing vasculitis. I. basic aspects].

Fritsch PO.

Hautarzt. 1991 Sep;42(9):599-604. German. No abstract available.

PMID:
1834613
33.

Acquired perforating dermatosis. Transepidermal elimination of DNA material and possible role of leukocytes in pathogenesis.

Zelger B, Hintner H, Auböck J, Fritsch PO.

Arch Dermatol. 1991 May;127(5):695-700.

PMID:
2024988
34.

[Psychosomatics--an urge?].

Klein GF, Fritsch PO.

Hautarzt. 1991 Jan;42(1):57-8. German. No abstract available.

PMID:
2010291
35.

Eczema-like, erythematous, infiltrated plaques: a common side effect of subcutaneous heparin therapy.

Klein GF, Kofler H, Wolf H, Fritsch PO.

J Am Acad Dermatol. 1989 Oct;21(4 Pt 1):703-7.

PMID:
2530252
36.

Morphological and phenotypical characterization of bone marrow-derived dendritic Thy-1-positive epidermal cells of the mouse.

Romani N, Tschachler E, Schuler G, Aberer W, Ceredig R, Elbe A, Wolff K, Fritsch PO, Stingl G.

J Invest Dermatol. 1985 Jul;85(1 Suppl):91s-95s.

37.

Lipids in the pathogenesis of ichthyosis: topical cholesterol sulfate-induced scaling in hairless mice.

Maloney ME, Williams ML, Epstein EH Jr, Law MY, Fritsch PO, Elias PM.

J Invest Dermatol. 1984 Oct;83(4):252-6.

38.

Differential lectin binding to mammalian keratinocytes and melanocytes in vitro.

Schuler G, Romani N, Fritsch PO.

Eur J Cell Biol. 1982 Apr;27(1):88-95.

PMID:
7084255
39.

Perturbations of membrane glycosylation in retinoid-treated epidermis.

Nemanic MK, Fritsch PO, Elias PM.

J Am Acad Dermatol. 1982 Apr;6(4 Pt 2 Suppl):801-8.

PMID:
6175671
40.
41.

Response of epidermal cell proliferation to orally administered aromatic retinoid.

Fritsch PO, Pohlin G, Längle U, Elias PM.

J Invest Dermatol. 1981 Sep;77(3):287-91.

42.

Retinoid effects on epidermal structure, differentiation, and permeability.

Elias PM, Fritsch PO, Lampe M, Williams ML, Brown BE, Nemanic M, Grayson S.

Lab Invest. 1981 Jun;44(6):531-40.

PMID:
6939940
43.

Expression of basement membrane zone antigens at the dermo-epibolic junction in organ cultures of human skin.

Hintner H, Fritsch PO, Foidart JM, Stingl G, Schuler G, Katz SI.

J Invest Dermatol. 1980 Apr;74(4):200-4.

44.

PUVA suppresses the proliferative stimulus produced by stripping on hairless mice.

Fritsch PO, Gschnait F, Kaaserer G, Brenner W, Chaikittisilpa S, Hönigsmann H, Wolff K.

J Invest Dermatol. 1979 Aug;73(2):188-90.

45.

Action of staphylococcal epidermolysin: further observations on its species specificity.

Fritsch PO, Kaaserer G, Elias PM.

Arch Dermatol Res. 1979 May 4;264(3):287-91.

PMID:
380473
46.
47.

[Cutaneous amebiasis].

Fritsch PO, Danner M, Kraus H.

Hautarzt. 1979 Feb;30(2):98-9. German. No abstract available.

PMID:
422366
48.

Augmentation of oral methoxsalen-photochemotherapy with an oral retinoic acid derivative.

Fritsch PO, Hönigsmann H, Jaschke E, Wolff K.

J Invest Dermatol. 1978 Apr;70(4):178-82. No abstract available.

49.

Nucleoside triphosphatase in Langerhans cells of autolytic skin.

Fritsch PO, Schellander FG.

Br J Dermatol. 1971 Jan;84(1):44-7. No abstract available.

PMID:
4102163
50.

Variable erythrokeratoderma. An unusual case.

Schellander FG, Fritsch PO.

Arch Dermatol. 1969 Dec;100(6):744-8. No abstract available.

PMID:
4243754

Supplemental Content

Loading ...
Support Center